SELECTA BIOSCIENCES INC 4
4 · SELECTA BIOSCIENCES INC · Filed Jun 30, 2017
Insider Transaction Report
Form 4
Siewers David
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2017-06-29$0.63/sh+5,770$3,635→ 9,652 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-06-29−5,770→ 9,614 totalExercise: $0.63Exp: 2020-09-06→ Common Stock (5,770 underlying) - Sale
Common Stock
2017-06-29$20.00/sh−9,616$192,322→ 36 total - Sale
Common Stock
2017-06-29$20.00/sh−36$720→ 0 total - Exercise/Conversion
Common Stock
2017-06-29$0.47/sh+3,846$1,808→ 3,882 total - Exercise/Conversion
Employee Stock Option (right to buy)
2017-06-29−3,846→ 0 totalExercise: $0.47Exp: 2019-09-19→ Common Stock (3,846 underlying)
Footnotes (5)
- [F1]The transactions reported for the 3,846 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- [F2]The transactions reported for the 5,770 shares were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 21, 2016.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.01, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange commission, upon request, full information regarding the number of shares sold at each separate price within the set forth herein.
- [F4]The 36 shares sold were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2016.
- [F5]All shares underlying this option are fully vested.